MRNS - Marinus Pharmaceuticals, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue----
Cost of Revenue----
Gross Profit----
Operating Expenses
Research Development28,19412,07621,70518,816
Selling General and Administrative8,9856,9676,5375,616
Non Recurring----
Total Operating Expenses37,17919,04328,24224,432
Operating Income or Loss-37,179-19,043-28,242-24,432
Income from Continuing Operations
Total Other Income/Expenses Net453145-401-418
Earnings Before Interest and Taxes-37,179-19,043-28,242-24,432
Interest Expense--159-464-475
Income Before Tax-36,726-18,898-28,643-24,850
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-36,726-18,898-28,643-24,850
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-36,726-18,898-28,643-24,850
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-36,726-18,898-28,643-24,850